Literature DB >> 19145442

[EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases].

P Kolar1, F Buttgereit.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19145442     DOI： 10.1007/s00393-008-0420-4

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN： 0340-1855            Impact factor:   1.372


× No keyword cloud information.
  10 in total

1.  EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases.

Authors:  J N Hoes; J W G Jacobs; M Boers; D Boumpas; F Buttgereit; N Caeyers; E H Choy; M Cutolo; J A P Da Silva; G Esselens; L Guillevin; I Hafstrom; J R Kirwan; J Rovensky; A Russell; K G Saag; B Svensson; R Westhovens; H Zeidler; J W J Bijlsma
Journal:  Ann Rheum Dis       Date:  2007-07-27       Impact factor: 19.103

2.  Insulin resistance after renal transplantation: the effect of steroid dose reduction and withdrawal.

Authors:  Karsten Midtvedt; Jøran Hjelmesaeth; Anders Hartmann; Kirsten Lund; Dag Paulsen; Thore Egeland; Trond Jenssen
Journal:  J Am Soc Nephrol       Date:  2004-12       Impact factor: 10.121

Review 3.  Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data.

Authors:  J A P Da Silva; J W G Jacobs; J R Kirwan; M Boers; K G Saag; L B S Inês; E J P de Koning; F Buttgereit; M Cutolo; H Capell; R Rau; J W J Bijlsma
Journal:  Ann Rheum Dis       Date:  2005-08-17       Impact factor: 19.103

Review 4.  Efficacy, tolerability, and upper gastrointestinal safety of celecoxib for treatment of osteoarthritis and rheumatoid arthritis: systematic review of randomised controlled trials.

Authors:  Jonathan J Deeks; Lesley A Smith; Matthew D Bradley
Journal:  BMJ       Date:  2002-09-21

5.  Efficacy of modified-release versus standard prednisone to reduce duration of morning stiffness of the joints in rheumatoid arthritis (CAPRA-1): a double-blind, randomised controlled trial.

Authors:  Frank Buttgereit; Gisela Doering; Achim Schaeffler; Stephan Witte; Stanislaw Sierakowski; Erika Gromnica-Ihle; Slawomir Jeka; Klaus Krueger; Jacek Szechinski; Rieke Alten
Journal:  Lancet       Date:  2008-01-19       Impact factor: 79.321

Review 6.  The effectiveness of five strategies for the prevention of gastrointestinal toxicity induced by non-steroidal anti-inflammatory drugs: systematic review.

Authors:  Lee Hooper; Tamara J Brown; Rachel Elliott; Katherine Payne; Chris Roberts; Deborah Symmons
Journal:  BMJ       Date:  2004-10-08

Review 7.  Prevention and treatment of glucocorticoid-induced osteoporosis with active vitamin D3 analogues: a review with meta-analysis of randomized controlled trials including organ transplantation studies.

Authors:  R N J de Nijs; J W G Jacobs; A Algra; W F Lems; J W J Bijlsma
Journal:  Osteoporos Int       Date:  2004-05-07       Impact factor: 4.507

8.  The effect of long-term glucocorticoid therapy on pituitary-adrenal responses to exogenous corticotropin-releasing hormone.

Authors:  R Schlaghecke; E Kornely; R T Santen; P Ridderskamp
Journal:  N Engl J Med       Date:  1992-01-23       Impact factor: 91.245

9.  Linear growth and final height in patients with systemic juvenile idiopathic arthritis treated with longterm glucocorticoids.

Authors:  Dominique Simon; Catherine Fernando; Paul Czernichow; Anne-Marie Prieur
Journal:  J Rheumatol       Date:  2002-06       Impact factor: 4.666

Review 10.  Effects of glucocorticoids on radiological progression in rheumatoid arthritis.

Authors:  J R Kirwan; J W J Bijlsma; M Boers; B J Shea
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.